David Bearss Resigns as Chief Scientific Officer to Join Huntsman Cancer Institute as Co-director of Center for Investigational Therapeutics

Retained as a Scientific Advisory Board Member & Consultant DUBLIN, Calif.--(BUSINESS WIRE)--Sep 21, 2009 - SuperGen Inc. (Nasdaq:SUPG) announced that, effective October 16, 2009, David Bearss, Ph.D., will resign as SuperGen's Chief Scientific...